A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The p53 protein is present in low amounts in normally growing cells and is activated in response to physiological insults. MDM2 regulates p53 either through inhibiting p53's transactivating function in the nucleus or by targeting p53 degradation in the cytoplasm. We identified a previously unknown nuclear export signal (NES) in the amino terminus of p53, spanning residues 11 to 27 and containing two serine residues phosphorylated after DNA damage, which was required for p53 nuclear export in colloboration with the carboxyl-terminal NES. Serine-15-phosphorylated p53 induced by ultraviolet irradiation was not exported. Thus, DNA damage-induced phosphorylation may achieve optimal p53 activation by inhibiting both MDM2 binding to, and the nuclear export of, p53.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A second NES located at the N-terminus of p53 within the MDM2-binding domain is inhibited by serine phosphorylations induced in response to DNA damage.”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [9]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Self-citationThe complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
Identification of a signal for rapid export of proteins from the nucleus
Wen, W., Meinkotht, J. L., Tsien, R. Y., & Taylor, S. S. (1995) · Cell · doi:10.1016/0092-8674(95)90435-2 · Cited by 1,190
Research works printed but not linked: 2
- ___, Cell Growth Differ. 12, 175 (2001).
- Supplementary material available on Science online at www.sciencemag.org/cgi/content/full/292/5523/1910/DC1.
Cited by
Items 201–300 of 377
Mulcahy, M. E., O’Brien, E. C., O’Keeffe, K. M., Vozza, E. G., Leddy, N., & McLoughlin, R. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565545 · Cited by 38
“Phosphorylation of p53 at serine 15 has been previously shown to inhibit a nuclear export signal at the amino terminal of p53 (36); therefore, high levels of p53ser15 may indicate retention of p53 in the nucleus.”
BackgroundWhite, D. E., Talbott, K. E., Arva, N. C., & Bargonetti, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1381 · Cited by 36
Mao, X. Y., Yang, H. Y., Song, J., Li, Y. H., & Ren, F. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062452m · Cited by 36
Dual Role of p300 in the Regulation of p53 Stability
Kawai, H., Nie, L., Wiederschain, D., & Yuan, Z.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107770200 · Cited by 35
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 42
“A similar effect is observed when cyclin A-Cdk2 phosphorylates Mdm2 on threonine 216, which also augments the Mdm2/ARF binding [125].”
BackgroundLu, C., Shao, C., Cobos, E., Singh, K. P., & Gao, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032895 · Cited by 38
“It has also been reported that phosphorylated Ser15 of p53 localized in the nucleus [51].”
BackgroundPhosphorylation regulates the interaction and complex formation between wt p53 protein and PARP‐1
Węsierska‐Gądek, J., Wojciechowski, J., & Schmid, G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10569 · Cited by 40
Tumor Suppressor SMAR1 Activates and Stabilizes p53 through Its Arginine-Serine-rich Motif
Jalota, A., Singh, K., Chavali, P. L., Kaul-Ghanekar, R., Jameel, S., & Chattopadhyay, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413200200 · Cited by 39
RetractedO’Hagan, H. M., & Ljungman, M. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207709 · Cited by 41
“It is thought that such phosphorylations block the binding of MDM2 to p53 resulting in the nuclear accumulation and stabilization of p53 (Shieh et al., 1997, 1999; Siliciano et al., 1997; Craig et al., 1999; Unger et al., 1999; Kapoor et al., 2000; Zhang and Xiong, 2001).”
BackgroundKoliou, X., Fedonidis, C., Kalpachidou, T., & Mangoura, D. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13401 · Cited by 38
“2007), APC (Zhang and Xiong 2001), or Alp7 – the yeast ortholog of TACC protein Mia1 (Okada et al.”
BackgroundInfluentialp53 Activation in Chronic Radiation-Treated Breast Cancer Cells
Xia, L., Paik, A. S., & Li, J. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0969 · Cited by 41
“It has been suggested that ARF family proteins regulate p53 activity (36, 53) via a negative regulation by MDM2 (53, 54).”
BackgroundUBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
Du, C., Wu, H., & Leng, R. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6555 · Cited by 32
“Posttranslational modification is important for regulating the function of p53 [5, 23].”
BackgroundIlluzzi, J. L., Vickers, C. A., & Kmiec, E. B. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9516-4 · Cited by 35
“It is widely accepted that p53 acts as an effector molecule in the cellular response to DNA damage (Appella and Anderson 2001; Sancar et al. 2004; Zhang and Xiong 2001).”
BackgroundChen, J., Dai, G., Wang, Y., Wang, S., Pan, F., Xue, B., Zhao, D., & Li, C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.047 · Cited by 32
“block export of p53 mediated by this NES thereby maintaining p53 within the nucleus [26].”
BackgroundP53 licensed to kill? Operating the assassin
Haupt, S. M., Louria‐Hayon, I., & Haupt, Y. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10311 · Cited by 37
“The need for two NESs is not yet clear, although onemaypostulate that theN-terminal NES may sense stresses such as DNA damage, through N-terminal phosphorylation, while the C-terminal NES may sense the p53/Mdm2 ratios within each cellular compartment at any given time.”
BackgroundInfluentialInterplay Between the Cell Cycle and Double-Strand Break Response in Mammalian Cells
Beishline, K., & Azizkhan‐Clifford, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_3 · Cited by 37
Boggs, K., & Reisman, D. (2005) · Oncogene · doi:10.1038/sj.onc.1209076 · Cited by 36
“…signals (NES), one in the N-terminus that is within the MDM2 binding domain and the second in the C-terminus (Stommel et al., 1999; Zhang and Xiong, 2001), and undergo cytoplasmic proteasome-mediated degradation. p53 can also be regulated by post-translational modifications, such…”
BackgroundGoodson, M. S., Crookes‐Goodson, W. J., Kimbell, J. R., & McFall‐Ngai, M. (2006) · Biological Bulletin · doi:10.2307/4134573 · Cited by 31
A spatial physiological model for p53 intracellular dynamics
Dimitrio, L., Clairambault, J., & Natalini, R. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.08.035 · Cited by 31
Therachiyil, L., Haroon, J., Sahir, F., Siveen, K. S., Shahab Uddin, M. S., Kuliński, M., Buddenkotte, J., Steinhoff, M. S., & Krishnankutty, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01744 · Cited by 31
DNA Damage Response and Cell Cycle Regulation in Pluripotent Stem Cells
Chen, A. C. H., Peng, Q., Fong, S. W., Lee, K. C., Yeung, W. S. B., & Lee, Y. L. (2021) · Genes · doi:10.3390/genes12101548 · Cited by 29
Transcription inhibition: A potential strategy for cancer therapeutics
Derheimer, F. A., Chang, C., & Ljungman, M. E. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.012 · Cited by 35
Hase, H., Kanno, Y., Kojima, H., Morimoto, C., Okumura, K., & Kobata, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209050200 · Cited by 33
Eom, C., Heo, W. D., Craske, M., Meyer, T., & Lehman, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400738101 · Cited by 27
Modification of serine 392 is a critical event in the regulation of p53 nuclear export and stability
Kim, Y.-Y., Park, B.-J., Kim, D. J., Kim, W.-H., Kim, S., Oh, K.-S., Lim, J.-Y., Kim, J., Park, C., & Park, S.-I. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.014 · Cited by 27
DNA damage response and GATA4 signaling in cellular senescence and aging-related pathology
Xiong, H., Hua, F., Dong, Y., Lin, Y., Ying, J., Liu, J., Wang, X., Zhang, L., & Zhang, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.933015 · Cited by 28
“The phosphorylation of p53 leads to an increase in p53 levels (Zhang and Xiong, 2001).”
BackgroundAnderson, C. W., & Appella, E. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50668-9 · Cited by 36
Szende, B., Farid, P., Végső, G., et al. (2004) · Pathology & Oncology Research · doi:10.1007/bf02893463 · Cited by 26
Skorta, I., Oren, M., Markwardt, C., Gutekunst, M., Aulitzky, W. E., & van der Kuip, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0548 · Cited by 24
“Loss of DNA damage–induced Ser(15) phosphorylation results in enhanced nuclear export (47).”
BackgroundDNA damage response in peritumoral regions of oesophageal cancer microenvironment
He, H., Tian, D., Guo, J., Liu, M., Chen, Z., Hamdy, F. C., Helleday, T., Su, M., & Ying, S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs301 · Cited by 24
Rahman, F., Ali, A., Khan, I. U., Duong, H., Yu, S., Lin, Y., Wang, H., Li, Z., & Zhang, D. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.014 · Cited by 25
Annonaa muricata Linn Leaf Induce Apoptosis in Cancer Cause Virus
Astirin, O. P., Artanti, A. N., Fitria, M. S., Perwitasari, E. A., & Prayitno, A. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.47146 · Cited by 24
Rieckmann, T., Kriegs, M., Nitsch, L., Hoffer, K., Rohaly, G., Köcher, S., Petersen, C., Dikomey, E., Dornreiter, I., & Dahm‐Daphi, J. (2012) · Oncogene · doi:10.1038/onc.2012.123 · Cited by 28
Abroudi, A. S., Samarasinghe, S., & Kulasiri, D. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.06.018 · Cited by 25
“Thus, the negative feedback loop between p53 and Mdm2 is an essential part of this module (Bar-Or et al., 2000; Geva‐Zatorsky et al., 2006; Kohn & Pommier, 2005; Meek, 2004; Nyberg et al., 2002; Zhang & Xiong, 2001).”
BackgroundZhang, R., & Misra, V. (2013) · Cell Cycle · doi:10.4161/cc.27053 · Cited by 24
“The protein p53 possesses nuclear localization and nuclear export signals, enabling it to shuttle between the nucleus and the cytoplasm.(15,16) To investigate the impact of Zhangfei on p53 nucleo-cytoplasmic shuttling, we monitored the p53 localization in ZF-expressing D-17 cells.”
BackgroundLiao, X., Chen, G.-T., Li, Y., Zhang, L., Liu, Q., Sun, H., & Guo, H. M. (2012) · Renal Failure · doi:10.3109/0886022x.2012.664470 · Cited by 23
“MDM2 inhibits p53 accumulation by targeting it for ubiquitination and proteasomal degradation.(46) Our experiments demonstrated a drastic decrease in p53 phosphorylation in rhALR-administrated rats, which indicates that rhALR increases the Bcl-2/Bax ratio by inactivating p53.”
Tickenbrock, L., Cramer, J., Vetter, I. R., & Müller, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203990200 · Cited by 30
Zhang, T., Birbrair, A., & Delbono, O. (2013) · Cytoskeleton · doi:10.1002/cm.21095 · Cited by 22
“The fact that TnT3 may contain many NLSs/NoLSs and NESs and the NH2-terminus could affect TnT conformation and function; TnT3 may work as a multilevel regulated transcription factor.”
Rahman, F., Ali, A., Khan, I. U., Duong, H., Guo, R., Wang, H., Li, Z., & Zhang, D. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.031 · Cited by 23
Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor
Liu, S., Qiao, W., Sun, Q., & Luo, Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01145 · Cited by 24
ATM and Chk2 kinase target the p53 cofactor Strap
Adams, C., Graham, A., Jansson, M., Coutts, A. S., Edelmann, M. J., Smith, L. M., Kessler, B. M., & Thangue, N. B. L. (2008) · EMBO Reports · doi:10.1038/embor.2008.186 · Cited by 26
“The N-terminal NES is regulated through DNA damage-dependent phosphoryl- ation, which assists p53 nuclear accumulation by hindering nuclear export (Zhang & Xiong, 2001).”
BackgroundLi, W., JIAN, W., Xiao-ping, X., YINGFENG, L., TAO, X., & XIAOYAN, X. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00636.x · Cited by 23
Anaphase-promoting complex/cyclosome controls HEC1 stability
Li, L., Zhou, Y., Wang, G.-F., Liao, S.-C., Ke, Y., Wu, W., Li, X.-H., Zhang, R.-L., & Fu, Y.-C. (2010) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00712.x · Cited by 20
Liu, Z., Lam, N., Wang, E., Virden, R. A., Pawel, B., Attiyeh, E. F., Maris, J. M., & Thiele, C. J. (2016) · Oncogene · doi:10.1038/onc.2016.179 · Cited by 20
“The p53 protein has two NESs and three NLSs (38, 40, 41): the N-terminal NES is regulated by phosphorylation events in response to DNA damage (40), and the NES in the tetramerization domain is masked upon p53 oligomerization (38).”
BackgroundThe p53 Tumor Suppressor Pathway and Cancer
Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 24
Hsu, C.-C., & Hu, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294272 · Cited by 21
“TheN-terminal NES is regulated by phosphorylation events in response to DNA damage (50), whereas the NES in the tetramerization domain is masked upon p53 oligomerization (49).”
BackgroundLiu, Q., Yu, J., Zhuo, X., Jiang, Q., & Zhang, C. (2010) · Cell Research · doi:10.1038/cr.2010.89 · Cited by 18
Wittlinger, M., Grabenbauer, G. G., Sprung, C. N., Sauer, R., & Distel, L. V. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701275432 · Cited by 23
“Additionally, Ser15 phosphorylation could stabilise p53 by preventing p53 nuclear export (Zhang & Xiong 2001) or allowing recruitment of transcription factors (Li et al. 2002).”
BackgroundHuang, S. H., Qu, L., Cuddihy, A. R., Ragheb, R., Taya, Y., & Koromilas, A. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206490 · Cited by 22
“These phosphorylations have been postulated to interfere with Mdm2 binding to, and/or nuclear export of, p53 (Zhang and Xiong, 2001), thereby preventing p53 inactivation and degradation through the proteasome pathway.”
Studies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 219
Lamy, V., Bousserouel, S., Gossé, F., Minker, C., Lobstein, A., & Raul, F. (2010) · Translational Oncology · doi:10.1593/tlo.10124 · Cited by 19
“In lupulone-treated SW480 cells, p53 was weakly phosphorylated at the level of serine-15 (as compared with SW620 cells) allowing the observed translocation of p53 from the nucleus into the cytoplasm where p53 might exert a protective effect on mitochondrial function [26,27].”
BackgroundTickets for p53 journey among organelles
Ferecatu, I., Rincheval, V., Mignotte, B., & Vayssiere, J.-L. (2009) · Frontiers in bioscience · doi:10.2741/3524 · Cited by 19
“The p53 human protein contains two such NES sequences, one in the Cterminal oligomerization domain (32), and the other one in N-terminal Mdm2-binding region (33).”
BackgroundInfluentialTransition of autophagy and apoptosis in fibroblasts depends on dominant expression of HIF-1α or p53
Li, M., Su, Y., Gao, X., Yu, J., Wang, Z., & Wang, X. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100187 · Cited by 20
“Low levels of p53 are expressed under normoxia and p53 is stably expressed during severe hypoxia (Shieh et al., 1997; Zhang and Xiong, 2001).”
BackgroundSmith, S. D., Enge, M., Bao, W., Thullberg, M., Costa, T. D. F., Olofsson, H., Gashi, B., Selivanova, G., & Strömblad, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.341917 · Cited by 23
“Nuclear export signal sequences within p53 can drive export upon p53 monomerization (38) or after DNA damage-dependent phosphorylation of Ser-15 (46).”
BackgroundStrategy and Tactics for Designing Analogs: Biochemical Characterization of the Large Molecules
Ahn, J., Kassees, K., Lee, T.-K., Manandhar, B., & Yousif, A. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12413-8 · Cited by 24
A Nuclear Export Sequence Located on a β-Strand in Fibroblast Growth Factor-1
Nilsen, T., Rosendal, K. R., Sørensen, V., Wesche, J., Olsnes, S., & Więdłocha, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611234200 · Cited by 18
Sebastian, T. B., Sreeja, S., & Thampan, R. V. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000026060.81570.35 · Cited by 18
“On the other hand, p38 binds p53 and induces phosphorylation of serine15 within the N-terminal nuclear export signal of p53 that blocks nuclear export [103, 104].”
Lee, W., Choi, J., Kim, H., Park, J.-H., Park, B. D., Cho, S. J., Lee, S., & Surh, Y. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.024 · Cited by 16
“Other studies have suggested that Ser15 phosphorylation is associated with p53 protein stabilization through inhibition of p53 nuclear export [27].”
BackgroundATM-mediated NuSAP phosphorylation induces mitotic arrest
Xie, P., Li, L., Xing, G., Tian, C., Yin, Y., He, F., & Zhang, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.135 · Cited by 19
Bridges, R. J., & Bradbury, N. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_103 · Cited by 19
Nuclear Expression of Thymidylate Synthase in Colorectal Cancer Cell Lines and Clinical Samples
Bissoon-Haqqani, S., Moyana, T. N., Jonker, D. J., Maroun, J. A., & Birnboim, H. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6642.2005 · Cited by 15
“Human TS appears to have a 4-2-1 leucinerich amino acid sequence motif at position 257-269 that is similar to the NES found in other species (Figure 7A) (Zhang and Xiong 2001).”
BackgroundRadioprotective role of H2S/CSE pathway in Chang liver cells
Pan, Y., Ye, S., Yuan, D., et al. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.08.007 · Cited by 14
A novel function of protein kinase B as an inducer of the mismatch repair gene hPMS2 degradation
Jia, J., Zhang, Y., Cai, J., Wang, J., Ding, H. J., Zhou, J., Fang, F., & Wang, Z. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.02.021 · Cited by 15
Self-citationSafa, M., Kazemi, A., Zaker, F., & Razmkhah, F. (2011) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2011.578140 · Cited by 16
“Ubiquitination, phosphorylation, and acetylation are posttranslational modifications that can affect p53 activity and stability (5,6).”
BackgroundRiley, K. J.-L., Ramírez-Alvarado, M., & Maher, L. J. (2007) · Biochemistry · doi:10.1021/bi061480v · Cited by 18
No exit strategy? No problem: APC inhibits β-catenin inside the nucleus: Figure 1.
Xiong, Y., & Kotake, Y. (2006) · Genes & Development · doi:10.1101/gad.1413206 · Cited by 16
Self-citationExogenous bacterial DnaK increases protein kinases activity in human cancer cell lines
Benedetti, F., Curreli, S., Gallo, R. C., & Zella, D. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02734-4 · Cited by 14
Lim, S., Hung, A. C., & Porter, A. G. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0331 · Cited by 13
“Because phosphorylation of p53 on Ser-15 is one gain-of-function indicator (21, 36), these data together show that p53 accumulates and is activated mainly in the nucleus before and during cell death induced by NO in SH-Sy5y cells.”
BackgroundLi, F., Mladenov, E., Dueva, R., Stuschke, M., Timmermann, B., & Iliakis, G. E. (2021) · Cells · doi:10.3390/cells11010063 · Cited by 13
“Phosphorylation on Serine 20 of p53 by CHK2/CHK1 helps stabilize p53 by uncoupling it from the MDM2 ubiquitin ligase [66,67], while ATM/ATR-mediated phosphorylations of MDM2 at Ser 395 [68] and p53 at Ser 15 and some other residues interfere with nuclear export and help activate p53 [69,70].”
BackgroundFenaroli, A., Vujanac, M., Cesare, D. D., & Zimarino, V. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.05.012 · Cited by 13
Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 protein
Menéndez, S., Higgins, M., Berkson, R. G., Edling, C., Lane, D. P., & Laín, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600752 · Cited by 12
“This ‘protective’ modification may be related to the appearance of the slower migrating form of full-length hMdm2 with LMB. Interestingly, the PI3-kinase inhibitor LY294002 induces the accumulation of full-length hMdm2 and an apparently equivalent N-terminal 32 kDa fragment of hMdm2 to that seen with LMB (Menendez S,…”
BackgroundInfluentialp53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
Römer, L., Klein, C., Dehner, A., Kessler, H., & Büchner, J. (2006) · Angewandte Chemie · doi:10.1002/ange.200600611 · Cited by 16
Protein Ubiquitination Modification in Pulmonary Fibrosis
Shen, J., Jiang, Y., Bu, W., Yu, M., Huang, R., Tang, C., Yang, Z., Gao, H., Su, L., Cheng, D., et al. (2025) · Comprehensive physiology · doi:10.1002/cph4.70013 · Cited by 11
“However, phosphorylation of p53 at Ser15 can weaken the p53-MDM2 interaction and reduce p53 nuclear export (Shieh et al. 1997; Zhang and Xiong 2001). p53 is a well-recognized marker of aging and a major regulator of key aging characteristics, such as genomic instability, mitochondrial dysfunction,…”
Yamauchi, M., Suzuki, K., Kodama, S., & Watanabe, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.175 · Cited by 12
Huang, J., & Fisher, R. A. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)86005-5 · Cited by 11
Cytoplasmic Translocation of p53 by Human Cytomegalovirus Infection
Kwon, Y., Kim, J., Kim, J. H., & Hwang, E. S. (2013) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2013.43.4.297 · Cited by 8
Godon, C., Coullet, S., Baus, B., Alonso, B., Davin, A., Delcuze, Y., Marchetti, C., Hainaut, P. L., Kazmaier, M., & Quéméneur, É. (2005) · Oncogene · doi:10.1038/sj.onc.1208785 · Cited by 10
“This stress-induced translocation is thought to be regulated by inhibition of nuclear export mediated through masking the Cterminal NES due to tetramer formation (Stommel et al., 1999) and/or through inactivation of N-terminal NES consecutive to stress-induced phosphorylations at several serine S15 and S20 (Zhang and…”
BackgroundPotential effects of CRM1 inhibition in mantle cell lymphoma
Zhang, K.-J., & Wang, M. L. (2012) · Chinese Journal of Cancer Research · doi:10.1007/s11670-012-0278-5 · Cited by 8
Activation et modifications post-traductionnelles de p53 après dommage de l’ADN
Leblanc, V., & May, P. (2002) · médecine/sciences · doi:10.1051/medsci/2002185577 · Cited by 16
“La phosphorylation de résidus dans la région N-terminale (sérines 15, 20, 33 et thréonine 18) de p53 est nécessaire pour régler sa fixation à MDM2 ainsi que sa localisation nucléaire [15, 16].”
BackgroundSerine 396 of PDK1 is required for maximal PKB activation
Moon, Z., Wang, Y., Aryan, N., Mousseau, D. D., & Scheid, M. P. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.07.015 · Cited by 8
X-irradiation reduces the proliferation of astrocytes by cell cycle arrest
Wang, Q., Xu, Y., Xie, M.-J., Yu, Z., Qin, Y., Wang, W., & Zhu, Z. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.04.067 · Cited by 8
Maki, C. G. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_8 · Cited by 11
Rollo, C. D. (2007) · NATO science for peace and security series. C, Environmental security · doi:10.1007/978-1-4020-6335-0_13 · Cited by 8
“Phosphorylation following DNA damage can mask this signal (Zhang and Xiong, 2001a).”
BackgroundGatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 10
“Alternatively, conditions that reduce MDM2p53 association should also reduce p53 C-terminal ubiquitination, which could also reduce p53 nuclear export by preventing unmasking of the Cterminal NES (see above).”
BackgroundInfluentialVikhanskaya, F., & Broggini, M. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19013-9 · Cited by 8
Węsierska‐Gądek, J. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0175 · Cited by 7
Choi, S., Koh, D., Cho, S.-Y., Kim, M.-K., Kim, K., & Hur, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008100 · Cited by 7
“Ser-15 phosphorylation might stabilize p53 by preventing p53 nuclear export (14).”
BackgroundSaito, T., Abe, D., & Nogata, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.129 · Cited by 7
p53 N-Terminal Ser-15∼P and Ser-20∼P Levels in Squamous Cell Lung Cancer after Radio/Chemotherapy
Mróz, R. M., Hołownia, A., Chyczewska, E., Chyczewski, L., & Braszko, J. J. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0077oc · Cited by 8
“Ser15 or Ser33 are thought to regulate transcription, Ser15 and Ser20 are implicated in murine double minute (MDM2) protein binding which targets p53 for degradation, whereas C-terminal modifications (both phosphorylation and acetylation) are thought to regulate principally the site-specific binding function of p53 (9…”
BackgroundRegulation of Nucleo-Cytoplasmic Transport of the Aryl Hydrocarbon Receptor
Kawajiri, K., & Ikuta, T. (2004) · Eisei kagaku · doi:10.1248/jhs.50.215 · Cited by 8
Lucanus, A. J., Thike, A. A., Tan, X. F., Lee, K. W., Guo, S., King, V. P. C., Yap, V. B., Bay, B., Tan, P. H., & Yip, G. W. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06426-x · Cited by 6
Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer
Nguyen, P. T., Shimojukkoku, Y., Kajiya, Y., Oku, Y., Tomishima, A., Shima, K., & Sasahira, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300446 · Cited by 6
Li, X., Feng, Y., Yan, M., Tu, X., Xie, B., Ni, F., Qu, C., & Chen, J.-G. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa011 · Cited by 9
Dimitrio, L., Clairambault, J., & Natalini, R. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 7
Li, D.-Y., Hu, X., Tian, Z., Ning, Q.-W., Liu, J.-Q., Yue, Y., Yuan, W., Meng, B., Li, J.-L., Zhang, Y., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01467-6 · Cited by 5
“Through direct interaction, Tagln might induce conformational changes in p53, optimizing its nuclear localization signal exposure and importin binding ef fi ciency [38].”
Self-citationZhang, J., Wu, H., Huang, Y., Yang, Y., Yekefenhazi, D., Zou, W., & Han, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073251 · Cited by 5
“Research has shown that p53 also enhances antiviral immunity by regulating a set of antiviral genes, including cytokines and interferon-related genes [46].”
MDM2: RING Finger Protein and Regulator of p53
Wu, L., & Maki, C. G. (2005) · Springer eBooks · doi:10.1007/0-387-27421-9_34 · Cited by 6
Ubiquitin Family Members in the Regulation of the Tumor Suppressor p53
Xirodimas, D. P., & Scheffner, M. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_10 · Cited by 5
Wang, Y., Zhou, X., Weinstein, E., Maryles, B., Zhang, Y., Moore, J. O., Gao, D., Atencio, D. P., Rosenstein, B. S., Lebwohl, M., et al. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00282.x · Cited by 5
“001) but not for UVA-BaP treatment (P(2) = 0.”
BackgroundSelf-citation
Metadata
- Authors
- Zhang, Y., & Xiong, Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Zhang, Yanping
- Xiong, Yue
- Venue
- Science
- Published
- 2001-06-08
- Volume
- 292
- Issue
- 5523
- Pages
- 1910-1915
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2118411078
- Semantic Scholar
- a7474f1954c3ad65ad4fe27e1c7cb5790d7a8187
- Cited by
- 378
- References
- 28
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 12 · 2020: 7 · 2019: 8 · 2018: 9 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 13 · 2013: 17 · 2012: 18
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (K01CA087580, R01CA065572, CA 65572)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- p53, nuclear export signal, serine phosphorylation, DNA damage response, MDM2, UV irradiation, p53 activation, protein degradation
- MeSH terms
- Amino Acid Sequence, Animals, Cell Fusion, Cell Line, Cell Nucleus, Cells, Cultured, Cytoplasm, DNA Damage, Molecular Sequence Data, Mutation, Nuclear Proteins, Phosphorylation, Phosphoserine, Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Ubiquitins, Ultraviolet Rays, Tumor Suppressor Protein p53, Protein Structure, Tertiary, Protein Sorting Signals, Active Transport, Cell Nucleus, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.